Taking cues from convalescence to improve vaccines against hepatitis C virus

Hepatitis C virus (HCV) infection remains a worldwide public health issue despite direct-acting antivirals. A substantial proportion of infected individuals (15%–45%) spontaneously clear repeated HCV infections with genetically different viruses by generating broadly neutralizing antibodies (bNAbs)....

Descripción completa

Detalles Bibliográficos
Autores principales: Sreekumar, Bharath K., Taha, Taha Y., Ott, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337820/
https://www.ncbi.nlm.nih.gov/pubmed/35912856
http://dx.doi.org/10.1172/JCI161819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337820/
https://www.ncbi.nlm.nih.gov/pubmed/35912856
http://dx.doi.org/10.1172/JCI161819

Ejemplares similares